FSGEX
Price
$20.87
Change
+$0.12 (+0.58%)
Updated
Jun 12 closing price
Net Assets
74.28B
HSWSX
Price
$23.14
Change
+$0.12 (+0.52%)
Updated
Jun 12 closing price
Net Assets
9.56B
Interact to see
Advertisement

FSGEX vs HSWSX

Header iconFSGEX vs HSWSX Comparison
Open Charts FSGEX vs HSWSXBanner chart's image
FSGEX vs HSWSX Comparison Chart in %
View a ticker or compare two or three
VS
FSGEX vs. HSWSX commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSGEX is a Buy and HSWSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSGEX has more cash in the bank: 74.3B vs. HSWSX (9.56B). FSGEX pays higher dividends than HSWSX: FSGEX (2.64) vs HSWSX (2.25). FSGEX was incepted earlier than HSWSX: FSGEX (17 years) vs HSWSX (10 years). HSWSX (1.11) is less costly to investors than FSGEX (0.01). HSWSX is a more actively managed with annual turnover of: 35.00 vs. FSGEX (8.00). FSGEX (0) and HSWSX (0) have matching initial minimum investment requirements. FSGEX annual gain was more profitable for investors over the last year : 28.94 vs. HSWSX (14.20). FSGEX return over 5 years is better than : 50.82 vs. HSWSX (34.80).
FSGEXHSWSXFSGEX / HSWSX
Total Expense Ratio0.011.111%
Annual Report Gross Expense Ratio0.011.111%
Fund Existence17 years10 years-
Gain YTD14.0446.981201%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets74.3B9.56B777%
Annual Yield % from dividends2.642.25118%
Returns for 1 year28.9414.20204%
Returns for 3 years67.4247.86141%
Returns for 5 years50.8234.80146%
Returns for 10 years150.60N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ESAGX17.110.33
+1.96%
Ashmore Emerging Markets Equity ESG A
VREQX11.860.12
+1.02%
NYLI CBRE Real Estate Class R6
AFVLX26.110.23
+0.89%
Applied Finance Select Investor
MKVIX18.750.08
+0.43%
MFS International Large Cap Value I
LGOAX51.590.08
+0.16%
Patient Opportunity A